Skip to main content
. 2012 Aug 30;3(9):988–997. doi: 10.18632/oncotarget.634

Figure 2. Treatment of tumors with the GHRH antagonist MIA-602 significantly suppressed the expression of GHRH and GHRH-R genes by tumors of HCC1806 and MX-1 human TNBC.

Figure 2

Vertical bars indicate ± SEM, n=12 tumors, * P < 0.01 vs. control.